comparemela.com

Shares of Eloxx Pharmaceuticals, Inc. (ELOX) are surging over 110% on Tuesday morning after its price target was raised by analysts at Oppenheimer Holdings Inc. from $50.

Related Keywords

,Eloxx Pharmaceuticals On ,Cancer Research Communications ,Oppenheimer Holdings Inc ,Nasdaq ,Eloxx Pharmaceuticals Inc ,Eloxx Pharmaceuticals ,Oppenheimer Holdings ,Novel Class ,Selectively Target ,Vijay Modur ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.